Intellia Therapeutics Inc.
NTLA | NASDAQ
$12.65
+$0.43 (+3.52%)
Sep 22, 2026, 12:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 155.46M | 189.18M | 226.75M | 523.51M | 123.41M | 160.02M |
Short-Term Investments | 294.42M | 412.33M | 685.48M | 669.12M | 625.28M | 437.35M |
Long-Term Investments | 35.54M | 44.26M | 154.51M | 142.32M | 425.05M | 4.75M |
Other Long-Term Assets | 155.25M | 260.22M | n/a | n/a | n/a | n/a |
Receivables | 9.47M | 8.52M | 36.46M | 3.77M | 2.03M | 2.13M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 68.36M | 29.83M | 49.65M | 20.41M | n/a | n/a |
Total Current Assets | 527.71M | 639.86M | 998.33M | 1.22B | 769.3M | 616.52M |
Property-Plant & Equipment | 123.63M | 246.67M | 148.14M | 161M | 100.11M | 55.06M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 314.42M | 551.15M | 302.65M | 303.32M | 525.16M | 59.81M |
Total Assets | 842.13M | 1.19B | 1.3B | 1.52B | 1.29B | 676.32M |
Account Payables | 20.25M | 14.59M | 7.45M | 5.15M | 9.65M | 10.46M |
Deferred Revenue | 7.29M | 20.66M | 22.14M | 43.84M | 63.76M | 22.54M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 23.07M | 24.08M | 6.89M | 21.78M | 20.36M | 10.92M |
Total Current Liabilities | 103.88M | 110.85M | 115.21M | 126.55M | 125.83M | 64.25M |
Long-Term Debt | 66.85M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 38.85M | 24.03M | n/a | n/a |
Total Long-Term Liabilities | 66.85M | 208.21M | 135.6M | 157.98M | 128.39M | 85M |
Total Liabilities | 170.73M | 319.06M | 250.81M | 284.53M | 254.22M | 149.25M |
Total Debt | 93.33M | 210.2M | 115.35M | 130.7M | 74.02M | 39.31M |
Book Value | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B | 527.07M |
Book Value Per Share | 6.20 | 8.82 | 11.83 | 16.05 | 14.67 | 9.41 |
Common Stock | 12K | 10K | 9K | 9K | 7K | 7K |
Retained Earnings | -2.59B | -2.18B | -1.66B | -1.18B | -703M | -435.11M |
Comprehensive Income | 1.03M | 605K | -2.26M | -7.46M | -2.63M | 1K |
Shareholders Equity | 671.39M | 871.96M | 1.05B | 1.24B | 1.04B | 527.07M |
Total Investments | 329.96M | 456.6M | 839.99M | 811.44M | 1.05B | 442.1M |
Add to Watchlist
Select watchlists to add or remove NTLA